Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

Avdili, A; Auer, M; Bernecker, C; Brislinger, D; Reinisch, A; Schlenke, P; Dorn, I. Molecular characterization of emerging hematopoiesis from human iPSCs
DocDay 2023; FEB 9, 2023; Graz, AUSTRIA. 2023. [Poster]

Avdili A, Auer M, Brislinger D, Matzhold EM, Bernecker C, Sundl M, Fuchs J, Schlenke P and Dorn I. Characterization of emerging iPSC-derived hematopoiesis and erythropoiesis inside three-dimensional cellular complexes (hemanoids)
Gordon Research Conference Red Cells; June 4-9, 2023; Newport, Rhode Island, USA. 2023. [Oral Communication]

Avdili A, Auer M, Brislinger D, Matzhold EM, Fuchs J, Bernecker C, Sundl M, Schlenke P and I. Dorn iPSC-derived cultured red blood cells resemble fetal liver erythropoiesis
11th GSCN Conference; Sept 13-15, 2023; Ulm, Germany. 2023. [Oral Communication]

Avdili, A; Auer, M; Bernecker, C; Reinisch, A; Schlenke, P; Dorn, I GENERATION OF A CD43 FLUORESCENT REPORTER IPSC LINE TO TRACK HEMATOPOIETIC DEVELOPMENT
EXP HEMATOL. 2022; 111: S58-S58. [Poster]
Web of Science FullText

Avdili, A; Bernecker, C; Frisch, MT; Reinisch, A; Schlenke, P; Dorn, I. Generation of a CD43 fluorescent reporter iPSC line to track hematopoietic development
24TH MEETING OF THE EUROPEAN RED CELL SOCIETY; April 7-11, 2022; Gazzado Schianno, Italy. 2022. [Poster]

Avdili1, A; Bernecker, C; Reinisch, A; Schlenke, P; Dorn, I. CRISPR/Cas9 mediated gene editing of human iPSC to track haematopoietic development
Sy-Stem Meeting 2022; APRIL 23-25, 2022; Vienna, Austria. 2022. [Poster]

Avdili, A; Bernecker, C; Frisch, MT, Reinisch, A; Schlenke, P; Dorn, I. Generation of a CD43 fluorescent reporter cell line using CRISPR/Cas9 gene editing to track hematopoietic development from human iPSCs
8th annual GSCN Conference; SEPT 23-25, 2020; Ulm, Germany. 2020. [Poster]
FullText

Mosinzer, S; Foßelteder, J; Avdili, A; Schlenke, P; Reinisch, A Generation of a TP53 isogenic cell line using CRISPR/Cas9 genome engineering
DocDay 2019, Medical University of Graz; Nov 21, 2019; Graz, AUSTRIA. 2019. [Poster]

Gali CC; Albrecher, N; Tam-Amersdorfer, C; Stracke, A; Sachdev, V; Sun, Y; Avdili, A; Fanaee-Danesh, E; Zandl-Lang, M; Reiter, M; Lass, A; Chandimalla, K; Panzenboeck, U Amyloid-beta impairs cerebrovascular insulin response by disrupting LRP-1 and IR-beta homeostasis in Alzheimer’s disease
Neurobiology of Brain Disorders, Gordon Research Conference 2018. The Role of Innate Immunity, Glia, Neurons, and the Blood-Brain Barrier in the Pathogenesis of Neurodegeneration.; AUG 5-10; Barcelona, SPAIN. 2018. [Poster]

Gali, CC; Albrecher, N; Tam-Amersdorfer, C; Stracke, A; Sachdev, V; Reichmann, F; Sun, Y;Avdili, A; Fanaee-Danesh, E; Zandl-Lang, M; Reiter, M; Kratky, D; Holzer, P; Lass, A; Kandimalla, K; Panzenboeck, U Amyloid beta impairs cerebrovascular insulin response by disrupting low-density lipoprotein receptor-related protein-1 and insulin receptor-beta homeostasis in Alzheimer’s disease.
DOCTORAL DAY 2018 @ Med Uni Graz; NOV 27, 2018; Graz, Austria. 2018. [Oral Communication]
FullText

Gali CC; Albrecher, N; Tam-Amersdorfer, C; Stracke, A; Sachdev, V; Sun, Y; Avdili, A; Fanaee-Danesh, E; Zandl-Lang, M; Reiter, M; Lass, A; Kandimalla, K; Panzenboeck, U IMPAIRED CENTRAL INSULIN RECEPTOR AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1 SIGNALING AXIS IN A MOUSE MODEL OF AD.
Advances in Alzheimer's and Parkinsons Therapies, an AAT-AD/PD Focus Meeting; March 15-18; Turin, ITALY. 2018. [Poster]